Clinical Trial Update: Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium [Phase 2]

View source ↗

Summary

Phase 2 trial results for CBT-001 ophthalmic solution in pterygium have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pterygium

Drugs mentioned

• CBT-001

Snippet

Sponsor: Cloudbreak Therapeutics, LLC | Conditions: Pterygium | Phase 2 | Status: COMPLETED | Results posted: 2020-02-24